Richard J Hawkins's Net Worth
$4.26 Million
Who is Richard J Hawkins?
Richard J Hawkins has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include PLUS THERAPEUTICS, INC., Savara Inc, LUMOS PHARMA, INC., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Richard J Hawkins's CIK is 0001307632
Past Insider Trading and Trends
2016 was Richard J Hawkins's most active year for acquiring shares with 9 total transactions. Richard J Hawkins's most active month to acquire stocks was the month of May. 2016 was Richard J Hawkins's most active year for disposing of shares, totalling 11 transactions. Richard J Hawkins's most active month to dispose stocks was the month of April. 2014 saw Richard J Hawkins paying a total of $227,500.00 for 111,771 shares, this is the most they've acquired in one year. In 2016 Richard J Hawkins cashed out on 278,993 shares for a total of $1,318,512.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PLUS THERAPEUTICS, INC. (PSTV) Snapshot price: $1.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +490,200.00% | 4.9K |
$2.04 | $10,000.08 | 4.9K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
∞
| 1 |
$1,000.00 | $1,000.00 | 1 |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +66.08% | 3.36K |
—
|
—
| 8.44K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 34.23K |
—
|
—
| 34.23K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +49.20% | 5.19K |
—
|
—
| 15.74K |
May 19
| |||
Form 4
|
∞
| 10.55K |
—
|
—
| 10.55K |
Jan 1
| |||
Form 4
|
∞
| 6.1K |
—
|
—
| 6.1K |
Jan 1
| |||
Form 4
| +99.16% | 10K |
—
|
—
| 20.09K |
Jan 1
| |||
Form 4
| +146.88% | 6K |
—
|
—
| 10.09K |
Jan 1
| |||
Form 4
| +30.01% | 943 |
—
|
—
| 4.08K |
Feb 9
| |||
Form 4
|
∞
| 3.14K |
—
|
—
| 3.14K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Savara Inc (SVRA) Snapshot price: $4.705
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +176.60% | 22.5K |
—
|
—
| 35.24K |
Dec 14
| |||
Form 4
| +570.58% | 10.84K |
$0.82 | $8,889.62 | 12.74K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +160.99% | 1.17K |
$0.65 | $761.80 | 1.9K |
Dec 7
| |||
Form 4
|
∞
| 728 |
$0.55 | $400.40 | 728 |
Dec 13 - Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
$5.81 | -$264,608.45 |
0
|
May 14 - May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUMOS PHARMA, INC. (LUMO) Snapshot price: $3
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.40% | 2.98K |
$2.84 | $8,457.52 | 753.09K |
Apr 1
| |||
Form 4
| -0.09% | -690.00 |
$3.01 | -$2,076.90 | 750.12K |
Feb 1
| |||
Form 4
| -0.20% | -1.52K |
$3.31 | -$5,037.82 | 750.8K |
Apr 1
| |||
Form 4
| +0.55% | 4.08K |
$3.52 | $14,375.68 | 752.33K |
Feb 1
| |||
Form 4
| +118.32% | 2.42K |
$8.84 | $21,402.16 | 4.47K |
Sep 21 - Sep 23
| |||
Form 4
|
∞
| 2.05K |
$8.72 | $17,857.15 | 2.05K |
Sep 19 - Sep 20
| |||
Form 4
| -0.20% | -1.47K |
$9.23 | -$13,531.18 | 748.24K |
Apr 1
| |||
Form 4
| +0.58% | 4.33K |
$10.02 | $43,356.54 | 749.71K |
Feb 1
| |||
Form 4
| -0.20% | -1.52K |
$12.25 | -$18,644.50 | 745.38K |
Apr 1
| |||
Form 4
| +0.31% | 2.33K |
—
|
—
| 746.9K |
Feb 1
| |||
Form 4
| +3.47% | 25K |
—
|
—
| 744.58K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.36K |
$11.18 | -$272,378.34 |
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
$6.39 | -$956,724.00 | 24.36K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 24.36K |
$7.78 | $11.67 | 24.36K |
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
$6.27 | -$27,426.85 |
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
$6.30 | -$63,075.42 |
0
|
May 29
| |||
Form 4
| -100.00% | -11.98K |
$9.44 | -$113,144.83 |
0
|
May 26
| |||
Form 4
| -23.59% | -3.70K |
$9.71 | -$35,913.68 | 11.98K |
May 21
| |||
Form 4
| -54.42% | -18.73K |
$9.16 | -$171,571.16 | 15.68K |
May 14
| |||
Form 4
| -31.18% | -15.59K |
$8.80 | -$137,136.67 | 34.41K |
Dec 10 - Dec 11
| |||
Form 4
|
∞
| 50K |
$4.55 | $227,500.00 | 50K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||